References
- Aschroft G W., Eccleston D, Murray L G., Glen A IM, Crawford T BB, Pullar I A., Shields P J., Walter D S., Blackburn I M., Lonergan M. Modified amine hypothesis for the aetiology of affective illness. Lancet 1972; II(7777)573–577
- Dillon N, Chung S, Kelly J, O'Malley K. Age and beta-adrenoceptor-mediated function. Clin. Pharmacol. Ther. 1980; 27: 769–772
- Extein I, Tallman J, Smith C C., Goodwin F K. Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiatry Research 1979; 1: 191–197
- Feighner J P., Robins E, Guze S B., Woodruff R A., Jr, Winocur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatry 1972; 26: 57–63
- Geisler A, Klysner R. Cyclic AMP, neurotransmission, and mood-modifying drugs. Prog. Pharmacol. 1980; 4: 143–149
- Pandey G N., Dysken M W., Garver D L., Davis J M. Beta-adrenergic receptor function in affective illness. Am. J Psychiatry 1979; 136: 675–678
- Rafaelsen O J. Manic-depressive psychosis or manic-melancholic mode. Dan. Med. Bull. 1974; 21: 81–87
- Schildkraut J J. The catecholamine hypothesis of affective disorders: a review of the supporting evidence. Am. J. Psychiatry 1965; 122: 509–522
- Sulser F. New cellular mechanisms of antidepressant drugs. New Frontiers in Psychotropic Drug Research, S Fielding, R C. Effland. Futura Publishing Company. 1980; 29–50
- Treiser S, Kellar K J. Lithium effects on adrenergic receptor supersensitivity in rat brain. Eur. J. Pharmacol. 1979; 58: 85–86